LENZ Therapeutics, Inc. (LENZ)
3.79
+0.20
(+5.57%)
USD |
NASDAQ |
Oct 06, 16:00
3.80
+0.01
(+0.26%)
After-Hours: 20:00
LENZ Therapeutics Price : 3.79 for Oct. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 06, 2026 | 3.60 | 3.84 | 3.60 | 3.79 | 682818.0 |
| Oct 05, 2026 | 3.60 | 3.60 | 3.455 | 3.59 | 777424.0 |
| Oct 02, 2026 | 3.84 | 3.84 | 3.51 | 3.58 | 1.127M |
| Oct 01, 2026 | 3.85 | 3.91 | 3.79 | 3.79 | 738896.0 |
| Sep 30, 2026 | 3.90 | 3.90 | 3.75 | 3.84 | 786205.0 |
| Sep 29, 2026 | 3.96 | 3.97 | 3.79 | 3.86 | 645153.0 |
| Sep 28, 2026 | 3.89 | 3.995 | 3.68 | 3.96 | 712696.0 |
| Sep 25, 2026 | 3.75 | 4.00 | 3.66 | 3.915 | 923819.0 |
| Sep 24, 2026 | 3.75 | 3.75 | 3.595 | 3.72 | 1.009M |
| Sep 23, 2026 | 4.14 | 4.14 | 3.735 | 3.76 | 765642.0 |
| Sep 22, 2026 | 4.10 | 4.175 | 4.07 | 4.13 | 511018.0 |
| Sep 21, 2026 | 4.12 | 4.125 | 4.00 | 4.08 | 776671.0 |
| Sep 18, 2026 | 4.10 | 4.14 | 4.04 | 4.07 | 735160.0 |
| Sep 17, 2026 | 4.23 | 4.278 | 4.01 | 4.13 | 889179.0 |
| Sep 16, 2026 | 4.23 | 4.285 | 4.12 | 4.14 | 762567.0 |
| Sep 15, 2026 | 4.44 | 4.44 | 4.205 | 4.23 | 819744.0 |
| Sep 14, 2026 | 4.53 | 4.60 | 4.42 | 4.47 | 744336.0 |
| Sep 11, 2026 | 4.71 | 4.77 | 4.50 | 4.52 | 978253.0 |
| Sep 10, 2026 | 4.85 | 4.88 | 4.68 | 4.72 | 569055.0 |
| Sep 09, 2026 | 5.31 | 5.405 | 4.885 | 4.91 | 705802.0 |
| Sep 08, 2026 | 5.95 | 5.95 | 5.32 | 5.33 | 642872.0 |
| Sep 04, 2026 | 5.75 | 5.98 | 5.615 | 5.96 | 488957.0 |
| Sep 03, 2026 | 5.90 | 5.97 | 5.65 | 5.83 | 835136.0 |
| Sep 02, 2026 | 5.21 | 5.81 | 5.21 | 5.80 | 993294.0 |
| Sep 01, 2026 | 5.17 | 5.305 | 5.00 | 5.23 | 605582.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Impact BioMedical, Inc. | 4.68 |
| Enveric Biosciences, Inc. | 1.47 |
| Liquidia Corp. | 25.91 |
| Aquestive Therapeutics, Inc. | 4.61 |
| ANI Pharmaceuticals, Inc. | 71.52 |
Price Related Metrics
| PS Ratio | 5.398 |
| PEG Ratio | -0.0081 |
| Price to Book Value | 0.543 |
| Earnings Yield | -107.7% |
| Market Cap | 119.07M |
| PEGY Ratio | -0.0081 |